Hart K - Search Results

1

Hamdan M, Hart K, Fitzpatrick A. Hamdan M, et al. Among authors: hart k. Am Heart J. 1996 May;131(5):1046-7. doi: 10.1016/s0002-8703(96)90196-9. Am Heart J. 1996. PMID: 8615297 No abstract available.

2

Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras.

Galvin BD, Hart KC, Meyer AN, Webster MK, Donoghue DJ. Galvin BD, et al. Among authors: hart kc. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7894-9. doi: 10.1073/pnas.93.15.7894. Proc Natl Acad Sci U S A. 1996. PMID: 8755573 Free PMC article.

3

Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation.

Weisstein JS, Delgado E, Steinbach LS, Hart K, Packman S. Weisstein JS, et al. Among authors: hart k. J Pediatr Orthop. 2004 Jan-Feb;24(1):97-101. doi: 10.1097/00004694-200401000-00019. J Pediatr Orthop. 2004. PMID: 14676543

4

Methylmalonic acidemia, cobalamin C type, presenting with cutaneous manifestations.

Howard R, Frieden IJ, Crawford D, McCalmont T, Levy ML, Rosenblatt DS, Sweetman L, Goodman SI, Ohnstad C, Hart K, Berrios M, Packman S. Howard R, et al. Among authors: hart k. Arch Dermatol. 1997 Dec;133(12):1563-6. Arch Dermatol. 1997. PMID: 9420542 Review.

5

The v-sis oncoprotein loses transforming activity when targeted to the early Golgi complex.

Hart KC, Xu YF, Meyer AN, Lee BA, Donoghue DJ. Hart KC, et al. J Cell Biol. 1994 Dec;127(6 Pt 2):1843-57. doi: 10.1083/jcb.127.6.1843. J Cell Biol. 1994. PMID: 7806564 Free PMC article.

6

Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain.

Robertson SC, Meyer AN, Hart KC, Galvin BD, Webster MK, Donoghue DJ. Robertson SC, et al. Among authors: hart kc. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4567-72. doi: 10.1073/pnas.95.8.4567. Proc Natl Acad Sci U S A. 1998. PMID: 9539778 Free PMC article.

7

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.

Hart KC, Robertson SC, Kanemitsu MY, Meyer AN, Tynan JA, Donoghue DJ. Hart KC, et al. Oncogene. 2000 Jul 6;19(29):3309-20. doi: 10.1038/sj.onc.1203650. Oncogene. 2000. PMID: 10918587

8

Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase.

Bell CA, Tynan JA, Hart KC, Meyer AN, Robertson SC, Donoghue DJ. Bell CA, et al. Among authors: hart kc. Mol Biol Cell. 2000 Oct;11(10):3589-99. doi: 10.1091/mbc.11.10.3589. Mol Biol Cell. 2000. PMID: 11029057 Free PMC article.

9

Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation.

Hart KC, Robertson SC, Donoghue DJ. Hart KC, et al. Mol Biol Cell. 2001 Apr;12(4):931-42. doi: 10.1091/mbc.12.4.931. Mol Biol Cell. 2001. PMID: 11294897 Free PMC article.

10

Derivatives of activated H-ras lacking C-terminal lipid modifications retain transforming ability if targeted to the correct subcellular location.

Hart KC, Donoghue DJ. Hart KC, et al. Oncogene. 1997 Feb 27;14(8):945-53. doi: 10.1038/sj.onc.1200908. Oncogene. 1997. PMID: 9050994 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

941 results

Search Page

Filters